News: Critics Favor Disclosing More Clinical Data on New Drug Risks


May 11, 2011

Drug regulators are being accused of being more concerned with protecting the profits of pharmaceutical companies than safeguarding the lives of patients.

The charge comes from doctors who spent three years battling with the European Medicines Agency (EMA) to extract the results of clinical trials carried out by drug companies on anti-obesity pills. The EMA, which gave the drugs a marketing licence, refused the requests.

Continue reading...

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments